• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • QMS/PMS

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

NMPA Suspended The Import, Sales And Use Of ExFuse Bone Graft Of HansBiomed Corp. After Remote QMS Audit

2023-07-17

National Medical Products Administration (NMPA) organized a remote QMS inspection of the ExFuse Bone Graft manufactured by HansBiomed…

China NMPA Newsletter – May 2023

2023-07-14

Featured Articles NMPA New Approvals in May 2023 In May 2023, NMPA approved 175 medical devices, including 27…

China NMPA Approves Innovative Head And Neck X-ray Stereotactic Radiosurgery System For Market

2023-06-27

On June 20, 2023, NMPA approved for the registration application of the cutting-edge medical device, the "Head and…

NMPA New Approvals In May 2023

2023-06-25

In May 2023, NMPA approved 175 medical devices, including 27 Class III imported products, 20 Class II imported…

China Releases Detailed Implementation Rules For Managing Human Genetic Resources

2023-06-25

On June 1, 2023, the Ministry of Science and Technology of China has announced the issuance of the…

NMPA Notice On The On-Site Inspection Guidelines Of Enterprise Quality Management Specialized In Medical Device Transportation And Storage Services As Appendix For Medical Device Good Supply Practice

2023-06-06

On May 24, 2023, NMPA releases new guidelines aimed at enhancing the supervision and management of medical device…

China NMPA Newsletter – April 2023

2023-06-01

Featured Articles NMPA New Approvals in April 2023 In March 2023, NMPA approved 290 medical devices, including 33…

NMPA New Plans On 118 Medical Device Registration Guidelines In 2023

2023-05-29

On April 4, NMPA releases the new plan for medical device registration guidelines in 2023 (NMPA, No. 6…

NMPA Further Enhancing The Surveillance On Radiofrequency Beauty Devices

2023-05-29

On April 12, the NMPA published Announcement No. 8 of 2023, which outlined the "Guidelines for Registration Review…

NMPA New Policy To Support China Real World Study

2023-05-29

On April 25, 2023, NMPA CMDE, Hainan local NMPA, and Hainan Boao Lecheng International Medical Tourism Pilot Zone…

NMPA New Approvals In April 2023

2023-05-22

In April 2023, NMPA approved 180 medical devices, including 21 Class III imported products, 33 Class II imported…

China NMPA Newsletter – March 2023

2023-04-28

Featured Articles NMPA New Approvals in March 2023 In March 2023, NMPA approved 290 medical devices, including 33…
« Prev...45678...121416...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7